A Phase 2 Open-Label, Multicenter Study To Evaluate Efficacy And Safety Of Zn-C3 In Subjects With High-Grade Serous Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
-
Enrollment
This study is currently enrolling. -
Research Area
Cancer Research -
Location
-
Principal Investigator
Robert Holloway -
Sponsor
GOG Partners & K-Group Beta, Inc
The purpose of this Study includes the following: To test the safety of the Study drug and how you will feel while taking the Study drug. To find out what effects, good and/or bad, it has on you and your cancer. To understand how the body absorbs and processes the Study drug by measuring the amount of the Study drug in the blood before, during and after receiving the Study drug. (This is called pharmacokinetics (PK) testing).
Enrollment Form
This study is currently enrolling.